Association of parity with risk of type 2 diabetes and related metabolic disorders

Diabetes Care
Anthony J G HanleyBernard Zinman

Abstract

The relationship between parity and risk of diabetes is controversial, and little information is available regarding associations between parity and measures of insulin resistance and beta-cell function. The objective of this study was to investigate the association between parity and risk of glucose intolerance and related metabolic disorders using data from a population-based study in a Native Canadian community. Female participants (n = 383, aged 12-79 years) provided fasting blood samples for the determination of glucose, insulin, C-peptide, and proinsulin concentrations. A 75-g oral glucose tolerance test was administered, and diabetes and impaired glucose tolerance were diagnosed according to World Health Organization criteria. Waist circumference and percent body fat were determined. Information regarding occurrence of live births and previously diagnosed diabetes was obtained from interviewer-administered questionnaires. Parity was associated with a significantly reduced risk of diabetes (nulliparous vs. >or=1 birth, odds ratio 0.43, 95% CI 0.19- 0.94, P < 0.05) after adjustment for age and waist circumference. In addition, nondiabetic nulliparous women had significantly elevated concentrations of fasting insulin and pr...Continue Reading

References

Jul 1, 1992·The American Journal of Medicine·J E MansonF E Speizer
Jul 13, 1991·BMJ : British Medical Journal·D R WilliamsC N Hales
Aug 1, 1990·Diabetes Care·E J BoykoA E Baron
Nov 2, 1989·The New England Journal of Medicine·D Kritz-SilversteinD L Wingard
Jul 21, 1984·The Medical Journal of Australia·F I MartinP Hammond
Aug 15, 1994·American Journal of Epidemiology·D Kritz-SilversteinN J Friedlander
Sep 1, 1994·The American Journal of Medicine·M A CharlesW C Knowler
May 1, 1993·American Journal of Epidemiology·M Laakso
May 1, 1993·The Journal of Clinical Endocrinology and Metabolism·N M O'MearaK S Polonsky
Mar 1, 1996·The Journal of Clinical Endocrinology and Metabolism·A Dunaif, D T Finegood
Jun 3, 1999·Endocrinology and Metabolism Clinics of North America·C G Solomon

❮ Previous
Next ❯

Citations

May 20, 2009·Metabolic Syndrome and Related Disorders·Elham MousaviNizal Sarrafzadegan
Sep 4, 2004·BMC Women's Health·Jennifer Payne
Jun 11, 2009·The Journal of Clinical Endocrinology and Metabolism·Mary E RauschUNKNOWN Reproductive Medicine Network
Nov 26, 2009·Eating and Weight Disorders : EWD·A A Mansour, N A H Ajeel
Mar 3, 2007·Obstetrics and Gynecology·Erica P GundersonSteve Sidney
Aug 17, 2006·Journal of Women's Health·Adi CohenLori A Bastian
Jun 22, 2013·BJOG : an International Journal of Obstetrics and Gynaecology·N T MuellerM A Pereira
Jul 5, 2007·Clinical Endocrinology·Ravi RetnakaranAnthony J G Hanley
Nov 13, 2004·Diabetes Research and Clinical Practice·N W Cheung
Sep 10, 2005·American Journal of Obstetrics and Gynecology·Niranjan P JoshiCaroline H D Fall
Jan 19, 2015·Diabetologia·Deirdre K TobiasJorge E Chavarro
Oct 27, 2006·Diabetes Care·Wanda K NicholsonNeil R Powe
Apr 29, 2010·Diabetes Care·Angela G Fowler-BrownKenneth J Mukamal
Mar 16, 2017·Menopause : the Journal of the North American Menopause Society·Jin Hwi Kim, Sung Jong Lee
Jan 20, 2020·The Journal of Clinical Endocrinology and Metabolism·Catherine KimWilliam C Knowler
Apr 18, 2015·Endocrinology·Chellakkan Selvanesan Blesson, Chandrasekhar Yallampalli
Jun 26, 2020·Frontiers in Aging Neuroscience·Joon Hyung JungDong Young Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.